{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:32Z","timestamp":1792180052447,"version":"4.4.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2022\/R single\/046"],"award-info":[{"award-number":["2022\/R single\/046"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 20286"],"award-info":[{"award-number":["IG 20286"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["29677"],"award-info":[{"award-number":["29677"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PNRR CN00000041 NextGenerationEU - MUR"],"award-info":[{"award-number":["PNRR CN00000041 NextGenerationEU - MUR"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GU 335\/35-2"],"award-info":[{"award-number":["GU 335\/35-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veronesi Foundation","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}]},{"name":"Michael J. Fox Fondation","award":["MJFF-021303"],"award-info":[{"award-number":["MJFF-021303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,11,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multiple sclerosis (MS) is characterized by invasion of the brain by effector memory T (T\n                    <jats:sub>EM<\/jats:sub>\n                    ) lymphocytes that have been activated by repeated auto-antigen stimulation. Existing therapies target these and other autoreactive lymphocytes but their side effects include general immunosuppression and toxicity. Because the Kv1.3 potassium channel is highly expressed by chronically activated autoreactive T\n                    <jats:sub>EM<\/jats:sub>\n                    s, we investigated whether specific targeting of mitochondrial Kv1.3 using the pharmacological inhibitor PAPTP could selectively kill these T\n                    <jats:sub>EM<\/jats:sub>\n                    s in patients and mice with MS. 1\u2009\u00b5M PAPTP targeted and reduced the number of autoreactive T\n                    <jats:sub>EM<\/jats:sub>\n                    s in blood samples from relapsing-remitting MS (RRMS) patients, leaving other T cell populations unaffected. Remarkably, pre-treatment of the entire T cell population with PAPTP during adoptive transfer of experimental autoimmune encephalomyelitis (EAE) killed T\n                    <jats:sub>EM<\/jats:sub>\n                    s and completely prevented disease onset in this mouse model. Moreover, PAPTP selectively eliminated activated T\n                    <jats:sub>EM<\/jats:sub>\n                    s and halted EAE progression when administered following disease onset. Our findings reveal the potential of PAPTP as an effective treatment for MS without adverse side effects.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00307-2","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:43:06Z","timestamp":1759156986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivo"],"prefix":"10.1038","volume":"17","author":[{"given":"Beatrice","family":"Angi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Varanita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Puthenparampil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0855-9402","authenticated-orcid":false,"given":"Valentina","family":"Scattolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8920-5181","authenticated-orcid":false,"given":"Mitra","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-8016","authenticated-orcid":false,"given":"Maguie","family":"El Boustani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Soddemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Biasutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Arcidiacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ongaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-0749","authenticated-orcid":false,"given":"Andrea","family":"Mattarei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-6149","authenticated-orcid":false,"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-1342","authenticated-orcid":false,"given":"Erich","family":"Gulbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-3947","authenticated-orcid":false,"given":"Ildiko","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"307_CR1","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3390\/jcm12206573","volume":"12","author":"M Adamczyk","year":"2023","unstructured":"Adamczyk M, Bartosi\u0144ska J, Raczkiewicz D, Kowal M, Surdacka A, Krasowska D, Michalak-Stoma A, Krasowska D (2023) The expression of activation markers CD25 and CD69 increases during biologic treatment of psoriasis. J Clin Med 12:6573","journal-title":"J Clin Med"},{"key":"307_CR2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","volume":"22","author":"KE Attfield","year":"2022","unstructured":"Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L (2022) The immunology of multiple sclerosis. Nat Rev Immunol 22:734\u2013750","journal-title":"Nat Rev Immunol"},{"key":"307_CR3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/emboj.2011.25","volume":"30","author":"F Baixauli","year":"2011","unstructured":"Baixauli F, Mart\u00edn-C\u00f3freces NB, Morlino G, Carrasco YR, Calabia-Linares C, Veiga E, Serrador JM, S\u00e1nchez-Madrid F (2011) The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse. EMBO J 30:1238\u20131250","journal-title":"EMBO J"},{"key":"307_CR4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","volume":"18","author":"GR Bantug","year":"2018","unstructured":"Bantug GR, Galluzzi L, Kroemer G, Hess C (2018) The spectrum of T cell metabolism in health and disease. Nat Rev Immunol 18:19\u201334","journal-title":"Nat Rev Immunol"},{"key":"307_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature08478","volume":"462","author":"I Bartholom\u00e4us","year":"2009","unstructured":"Bartholom\u00e4us I, Kawakami N, Odoardi F, Schl\u00e4ger C, Miljkovic D, Ellwart JW, Klinkert WE, Fl\u00fcgel-Koch C, Issekutz TB, Wekerle H et al (2009) Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462:94\u201398","journal-title":"Nature"},{"key":"307_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000484621","volume":"25","author":"KA Becker","year":"2017","unstructured":"Becker KA, Halmer R, Davies L, Henry BD, Ziobro-Henry R, Decker Y, Liu Y, Gulbins E, Fassbender K, Walter S (2017) Blockade of experimental multiple sclerosis by inhibition of the acid sphingomyelinase\/ceramide system. Neuro-Signals 25:88\u201397","journal-title":"Neuro-Signals"},{"key":"307_CR7","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/art.10968","volume":"48","author":"JJ Bednarski","year":"2003","unstructured":"Bednarski JJ, Warner RE, Rao T, Leonetti F, Yung R, Richardson BC, Johnson KJ, Ellman JA, Opipari AW Jr, Glick GD (2003) Attenuation of autoimmune disease in Fas-deficient mice by treatment with a cytotoxic benzodiazepine. Arthritis Rheum 48:757\u2013766","journal-title":"Arthritis Rheum"},{"key":"307_CR8","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4049\/jimmunol.166.2.936","volume":"166","author":"C Beeton","year":"2001","unstructured":"Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel AM, Gola M, Sabatier JM, Bernard D, Crest M, B\u00e9raud E (2001a) Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol 166:936\u2013944","journal-title":"J Immunol"},{"key":"307_CR9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1073858405278016","volume":"11","author":"C Beeton","year":"2005","unstructured":"Beeton C, Chandy KG (2005) Potassium channels, memory T cells, and multiple sclerosis. Neuroscientist 11:550\u2013562","journal-title":"Neuroscientist"},{"key":"307_CR10","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","volume":"98","author":"C Beeton","year":"2001","unstructured":"Beeton C, Wulff H, Barbaria J, Clot-Faybesse O, Pennington M, Bernard D, Cahalan MD, Chandy KG, Beraud E (2001b) Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 98:13942\u201313947","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR11","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1074\/jbc.M212868200","volume":"278","author":"C Beeton","year":"2003","unstructured":"Beeton C, Wulff H, Singh S, Botsko S, Crossley G, Gutman GA, Cahalan MD, Pennington M, Chandy KG (2003) A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem 278:9928\u20139937","journal-title":"J Biol Chem"},{"key":"307_CR12","doi-asserted-by":"crossref","unstructured":"Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR et al (2006) Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci USA 103:17414\u201317419","DOI":"10.1073\/pnas.0605136103"},{"issue":"86","key":"307_CR13","first-page":"51275","volume":"15","author":"S Bittner","year":"2014","unstructured":"Bittner S, Afzali AM, Wiendl H, Meuth SG (2014) Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. J Vis Exp 15(86):51275","journal-title":"J Vis Exp"},{"key":"307_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2012.08.021","volume":"238","author":"S Bittner","year":"2012","unstructured":"Bittner S, Bauer MA, Ehling P, Bobak N, Breuer J, Herrmann AM, Golfels M, Wiendl H, Budde T, Meuth SG (2012) The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosis. Exp Neurol 238:149\u2013155","journal-title":"Exp Neurol"},{"key":"307_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/1756285613487782","volume":"6","author":"S Bittner","year":"2013","unstructured":"Bittner S, Meuth SG (2013) Targeting ion channels for the treatment of autoimmune neuroinflammation. Ther Adv Neurol Disord 6:322\u2013336","journal-title":"Ther Adv Neurol Disord"},{"key":"307_CR16","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","volume":"26","author":"S Brahmachari","year":"2006","unstructured":"Brahmachari S, Fung YK, Pahan K (2006) Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 26:4930\u20134939","journal-title":"J Neurosci"},{"key":"307_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2019.04.013","volume":"102","author":"M Bronge","year":"2019","unstructured":"Bronge M, Ruhrmann S, Carvalho-Queiroz C, Nilsson OB, Kaiser A, Holmgren E, Macrini C, Winklmeier S, Meinl E, Brundin L et al (2019) Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis. J Autoimmun 102:38\u201349","journal-title":"J Autoimmun"},{"key":"307_CR18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O\u2019Sullivan D, Klein Geltink RI, Curtis JD, Chang CH, Sanin DE, Qiu J, Kretz O, Braas D, van der Windt GJ et al (2016) Mitochondrial dynamics controls T cell fate through metabolic programming. Cell 166:63\u201376","journal-title":"Cell"},{"key":"307_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","volume":"231","author":"MD Cahalan","year":"2009","unstructured":"Cahalan MD, Chandy KG (2009) The functional network of ion channels in T lymphocytes. Immunol Rev 231:59\u201387","journal-title":"Immunol Rev"},{"key":"307_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104068","volume":"50","author":"I Callegari","year":"2021","unstructured":"Callegari I, Derfuss T, Galli E (2021) Update on treatment in multiple sclerosis. Presse Med 50:104068","journal-title":"Presse Med"},{"key":"307_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100146","volume":"5","author":"CA Ca\u00f1as","year":"2022","unstructured":"Ca\u00f1as CA, Casta\u00f1o-Valencia S, Castro-Herrera F (2022) Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases. J Transl Autoimmun 5:100146","journal-title":"J Transl Autoimmun"},{"key":"307_CR22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.865686","volume":"12","author":"J Capera","year":"2022","unstructured":"Capera J, Navarro-P\u00e9rez M, Moen AS, Szab\u00f3 I, Felipe A (2022) The mitochondrial routing of the Kv1.3 channel. Front Oncol 12:865686","journal-title":"Front Oncol"},{"key":"307_CR23","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1182\/blood-2005-11-007237","volume":"108","author":"J Carrasco","year":"2006","unstructured":"Carrasco J, Godelaine D, Van Pel A, Boon T, van der Bruggen P (2006) CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 108:2897\u20132905","journal-title":"Blood"},{"key":"307_CR24","doi-asserted-by":"crossref","first-page":"14644","DOI":"10.1038\/ncomms14644","volume":"8","author":"EY Chiang","year":"2017","unstructured":"Chiang EY, Li T, Jeet S, Peng I, Zhang J, Lee WP, DeVoss J, Caplazi P, Chen J, Warming S et al (2017) Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun 8:14644","journal-title":"Nat Commun"},{"key":"307_CR25","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1212\/NXI.0000000000001075","volume":"8","author":"C Cruciani","year":"2021","unstructured":"Cruciani C, Puthenparampil M, Tomas-Ojer P, Jelcic I, Docampo MJ, Planas R, Manogaran P, Opfer R, Wicki C, Reindl M et al (2021) T-cell specificity influences disease heterogeneity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 8:e1075","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"307_CR26","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/eji.201948223","volume":"49","author":"S De Biasi","year":"2019","unstructured":"De Biasi S, Simone AM, Bianchini E, Lo Tartaro D, Pecorini S, Nasi M, Patergnani S, Carnevale G, Gibellini L, Ferraro D et al (2019) Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients. Eur J Immunol 49:2204\u20132221","journal-title":"Eur J Immunol"},{"key":"307_CR27","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416097121","volume":"121","author":"N Drosu","year":"2024","unstructured":"Drosu N, Anderson M, Bilodeau PA, Nishiyama S, Mikami T, Bobrowski-Khoury N, Cabot J, Housman D, Levy M (2024) CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation. Proc Natl Acad Sci USA 121:e2416097121","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR28","doi-asserted-by":"crossref","DOI":"10.1177\/17590914221112352","volume":"14","author":"JL Dupree","year":"2022","unstructured":"Dupree JL, Paez PM, Tiwari-Woodruff SK, Denton TT, Hensley K, Angeliu CG, Boullerne AI, Kalinin S, Egge S, Cheli VT et al (2022) Lanthionine ketimine ethyl ester accelerates remyelination in a mouse model of multiple sclerosis. ASN Neuro 14:17590914221112352","journal-title":"ASN Neuro"},{"key":"307_CR29","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s40265-023-01942-0","volume":"83","author":"G Edan","year":"2023","unstructured":"Edan G, Le Page E (2023) Escalation versus induction\/high-efficacy treatment strategies for relapsing multiple sclerosis: which is best for patients?. Drugs 83:1351\u20131363","journal-title":"Drugs"},{"key":"307_CR30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.20050687","volume":"202","author":"S Feske","year":"2005","unstructured":"Feske S, Prakriya M, Rao A, Lewis RS (2005) A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients. J Exp Med 202:651\u2013662","journal-title":"J Exp Med"},{"key":"307_CR31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","volume":"33","author":"S Feske","year":"2015","unstructured":"Feske S, Wulff H, Skolnik EY (2015) Ion channels in innate and adaptive immunity. Annu Rev Immunol 33:291\u2013353","journal-title":"Annu Rev Immunol"},{"key":"307_CR32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/10567","volume":"5","author":"A Fl\u00fcgel","year":"1999","unstructured":"Fl\u00fcgel A, Willem M, Berkowicz T, Wekerle H (1999) Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses. Nat Med 5:843\u2013847","journal-title":"Nat Med"},{"key":"307_CR33","doi-asserted-by":"crossref","first-page":"67ra68","DOI":"10.1126\/scitranslmed.3001975","volume":"3","author":"E Gatza","year":"2011","unstructured":"Gatza E, Wahl DR, Opipari AW, Sundberg TB, Reddy P, Liu C, Glick GD, Ferrara JL (2011) Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med 3:67ra68","journal-title":"Sci Transl Med"},{"key":"307_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-024-02730-0","volume":"147","author":"A Geladaris","year":"2024","unstructured":"Geladaris A, Torke S, Saberi D, Alankus YB, Streit F, Zechel S, Stadelmann-Nessler C, Fischer A, Boschert U, H\u00e4usler D et al (2024) BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair. Acta Neuropathol 147:75","journal-title":"Acta Neuropathol"},{"key":"307_CR35","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.4049\/jimmunol.1103095","volume":"188","author":"AR Gocke","year":"2012","unstructured":"Gocke AR, Lebson LA, Grishkan IV, Hu L, Nguyen HM, Whartenby KA, Chandy KG, Calabresi PA (2012) Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. J Immunol 188:5877\u20135886","journal-title":"J Immunol"},{"key":"307_CR36","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/ph17111474","volume":"17","author":"D H\u00e4usler","year":"2024","unstructured":"H\u00e4usler D, Weber MS (2024) Towards treating multiple sclerosis progression. Pharmaceuticals 17:1474","journal-title":"Pharmaceuticals"},{"key":"307_CR37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577392","volume":"349","author":"S Hawke","year":"2020","unstructured":"Hawke S, Zinger A, Juillard PG, Holdaway K, Byrne SN, Grau GE (2020) Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment. J Neuroimmunol 349:577392","journal-title":"J Neuroimmunol"},{"key":"307_CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Tr\u00e9panier MO, Giuliano V, Bazinet RP (2018) Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry 23:177\u2013198","journal-title":"Mol Psychiatry"},{"key":"307_CR39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K et al (2018) Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell 175:85\u2013100.e123","journal-title":"Cell"},{"key":"307_CR40","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1039\/D0CS01096K","volume":"50","author":"C Jiang","year":"2021","unstructured":"Jiang C, Huang H, Kang X, Yang L, Xi Z, Sun H, Pluth MD, Yi L (2021) NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications. Chem Soc Rev 50:7436\u20137495","journal-title":"Chem Soc Rev"},{"key":"307_CR41","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1089\/ars.2011.4073","volume":"18","author":"P Kesarwani","year":"2013","unstructured":"Kesarwani P, Murali AK, Al-Khami AA, Mehrotra S (2013) Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease. Antioxid Redox Signal 18:1497\u20131534","journal-title":"Antioxid Redox Signal"},{"key":"307_CR42","doi-asserted-by":"crossref","first-page":"eabd1471","DOI":"10.1126\/sciadv.abd1471","volume":"6","author":"M Khodoun","year":"2020","unstructured":"Khodoun M, Chimote AA, Ilyas FZ, Duncan HJ, Moncrieffe H, Kant KS, Conforti L (2020) Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus. Sci Adv 6:eabd1471","journal-title":"Sci Adv"},{"key":"307_CR43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/pri.23499","volume":"7","author":"R Klaver","year":"2013","unstructured":"Klaver R, De Vries HE, Schenk GJ, Geurts JJ (2013) Grey matter damage in multiple sclerosis: a pathology perspective. Prion 7:66\u201375","journal-title":"Prion"},{"key":"307_CR44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","volume":"19","author":"L Klotz","year":"2023","unstructured":"Klotz L, Antel J, Kuhlmann T (2023) Inflammation in multiple sclerosis: consequences for remyelination and disease progression. Nat Rev Neurol 19:305\u2013320","journal-title":"Nat Rev Neurol"},{"key":"307_CR45","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","volume":"169","author":"AP Kohm","year":"2002","unstructured":"Kohm AP, Carpentier PA, Anger HA, Miller SD (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169:4712\u20134716","journal-title":"J Immunol"},{"key":"307_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-014-0163-1","volume":"2","author":"M Koutrolos","year":"2014","unstructured":"Koutrolos M, Berer K, Kawakami N, Wekerle H, Krishnamoorthy G (2014) Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol Commun 2:163","journal-title":"Acta Neuropathol Commun"},{"key":"307_CR47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ddr.20467","volume":"72","author":"J Lam","year":"2011","unstructured":"Lam J, Wulff H (2011) The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Dev Res 72:573\u2013584","journal-title":"Drug Dev Res"},{"key":"307_CR48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/emmm.201200235","volume":"4","author":"L Leanza","year":"2012","unstructured":"Leanza L, Henry B, Sassi N, Zoratti M, Chandy KG, Gulbins E, Szabo I (2012) Inhibitors of mitochondrial Kv1.3 channels induce Bax\/Bak-independent death of cancer cells. EMBO Mol Med 4:577\u2013593","journal-title":"EMBO Mol Med"},{"key":"307_CR49","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2017.03.003","volume":"31","author":"L Leanza","year":"2017","unstructured":"Leanza L, Romio M, Becker KA, Azzolini M, Trentin L, Manago A, Venturini E, Zaccagnino A, Mattarei A, Carraretto L et al (2017) Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivo. Cancer Cell 31:516\u2013531.e510","journal-title":"Cancer Cell"},{"key":"307_CR50","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/leu.2013.56","volume":"27","author":"L Leanza","year":"2013","unstructured":"Leanza L, Trentin L, Becker KA, Frezzato F, Zoratti M, Semenzato G, Gulbins E, Szabo I (2013) Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 27:1782\u20131785","journal-title":"Leukemia"},{"key":"307_CR51","first-page":"93ra68","volume":"3","author":"LF Lee","year":"2011","unstructured":"Lee LF, Axtell R, Tu GH, Logronio K, Dilley J, Yu J, Rickert M, Han B, Evering W, Walker MG et al (2011) IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-\u03b2 in multiple sclerosis. Sci Transl Med 3:93ra68","journal-title":"Sci Transl Med"},{"key":"307_CR52","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215687","volume":"14","author":"M Letizia","year":"2022","unstructured":"Letizia M, Wang YH, Kaufmann U, Gerbeth L, Sand A, Brunkhorst M, Weidner P, Ziegler JF, B\u00f6ttcher C, Schlickeiser S et al (2022) Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease. EMBO Mol Med 14:e15687","journal-title":"EMBO Mol Med"},{"key":"307_CR53","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3390\/cancers14112618","volume":"14","author":"W Li","year":"2022","unstructured":"Li W, Wilson GC, Bachmann M, Wang J, Mattarei A, Paradisi C, Edwards MJ, Szabo I, Gulbins E, Ahmad SA et al (2022) Inhibition of a mitochondrial potassium channel in combination with gemcitabine and abraxane drastically reduces pancreatic ductal adenocarcinoma in an immunocompetent orthotopic murine model. Cancers 14:2618","journal-title":"Cancers"},{"key":"307_CR54","doi-asserted-by":"crossref","first-page":"29479","DOI":"10.1074\/jbc.M112.379594","volume":"287","author":"Z Li","year":"2012","unstructured":"Li Z, Liu WH, Han S, Peng BW, Yin J, Wu YL, He XH, Li WX (2012) Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model. J Biol Chem 287:29479\u201329494","journal-title":"J Biol Chem"},{"key":"307_CR55","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/eji.201040614","volume":"40","author":"J Ma","year":"2010","unstructured":"Ma J, McCarl CA, Khalil S, L\u00fcthy K, Feske S (2010) T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Eur J Immunol 40:3028\u20133042","journal-title":"Eur J Immunol"},{"key":"307_CR56","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.201343751","volume":"43","author":"YD Mahnke","year":"2013","unstructured":"Mahnke YD, Brodie TM, Sallusto F, Roederer M, Lugli E (2013) The who\u2019s who of T-cell differentiation: human memory T-cell subsets. Eur J Immunol 43:2797\u20132809","journal-title":"Eur J Immunol"},{"key":"307_CR57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1238171","volume":"14","author":"N Manolios","year":"2023","unstructured":"Manolios N, Papaemmanouil J, Adams DJ (2023) The role of ion channels in T cell function and disease. Front Immunol 14:1238171","journal-title":"Front Immunol"},{"key":"307_CR58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-2634-9","volume":"585","author":"E Miyauchi","year":"2020","unstructured":"Miyauchi E, Kim SW, Suda W, Kawasumi M, Onawa S, Taguchi-Atarashi N, Morita H, Taylor TD, Hattori M, Ohno H (2020) Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature 585:102\u2013106","journal-title":"Nature"},{"key":"307_CR59","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awt108","volume":"136","author":"M Mohme","year":"2013","unstructured":"Mohme M, Hotz C, Stevanovic S, Binder T, Lee JH, Okoniewski M, Eiermann T, Sospedra M, Rammensee HG, Martin R (2013) HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis. Brain 136:1783\u20131798","journal-title":"Brain"},{"key":"307_CR60","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1523\/JNEUROSCI.0453-06.2006","volume":"26","author":"LB Morales","year":"2006","unstructured":"Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR (2006) Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823\u20136833","journal-title":"J Neurosci"},{"key":"307_CR61","doi-asserted-by":"crossref","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1\u201313","DOI":"10.1042\/BJ20081386"},{"key":"307_CR62","volume":"15","author":"J Nam","year":"2021","unstructured":"Nam J, Koppinen TK, Voutilainen MH (2021) MANF is neuroprotective in early stages of EAE, and elevated in spinal white matter by treatment with dexamethasone. Front Cell Neurosci 15:640084","journal-title":"Front Cell Neurosci"},{"key":"307_CR63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.06.001","volume":"310","author":"BR Nielsen","year":"2017","unstructured":"Nielsen BR, Ratzer R, B\u00f6rnsen L, von Essen MR, Christensen JR, Sellebjerg F (2017) Characterization of na\u00efve, memory and effector T cells in progressive multiple sclerosis. J Neuroimmunol 310:17\u201325","journal-title":"J Neuroimmunol"},{"key":"307_CR64","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ijc.34281","volume":"152","author":"Y Peng","year":"2023","unstructured":"Peng Y, Tao Y, Zhang Y, Wang J, Yang J, Wang Y (2023) CD25: A potential tumor therapeutic target. Int J Cancer 152:1290\u20131303","journal-title":"Int J Cancer"},{"key":"307_CR65","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3181\/0705-RM-148","volume":"232","author":"LE Pereira","year":"2007","unstructured":"Pereira LE, Villinger F, Wulff H, Sankaranarayanan A, Raman G, Ansari AA (2007) Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaques. Exp Biol Med 232:1338\u20131354","journal-title":"Exp Biol Med"},{"key":"307_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti L, Willis CM, Krzak G, Hamel R, Pirvan L, Ionescu RB, Reisz JA, Prag HA, Garcia-Segura ME, Wu V et al (2024) Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628:195\u2013203","journal-title":"Nature"},{"key":"307_CR67","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn9361","volume":"10","author":"E Prosdocimi","year":"2024","unstructured":"Prosdocimi E, Carpanese V, Todesca LM, Varanita T, Bachmann M, Festa M, Bonesso D, Perez-Verdaguer M, Carrer A, Velle A et al (2024) BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway. Sci Adv 10:eadn9361","journal-title":"Sci Adv"},{"key":"307_CR68","unstructured":"Pyka-Fosciak G, Fosciak M, Wojcik B, Lis GJ, Litwin JA (2023) Histopatological parameters of the spinal cord in different phases of experimental autoimmune encephalomyelitis. A mouse model of multiple sclerosis examined by classical stainings combined with immunohistochemistry. J Physiol Pharmacol 74(4):465\u2013472."},{"key":"307_CR69","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","volume":"4","author":"A Ribas","year":"2016","unstructured":"Ribas A, Shin DS, Zaretsky J, Frederiksen J, Cornish A, Avramis E, Seja E, Kivork C, Siebert J, Kaplan-Lefko P et al (2016) PD-1 blockade expands intratumoral memory T cells. Cancer Immunol Res 4:194\u2013203","journal-title":"Cancer Immunol Res"},{"key":"307_CR70","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1177\/1352458512447704","volume":"18","author":"F Rinaldi","year":"2012","unstructured":"Rinaldi F, Calabrese M, Seppi D, Puthenparampil M, Perini P, Gallo P (2012) Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. Mult Scler 18:1760\u20131767","journal-title":"Mult Scler"},{"key":"307_CR71","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","volume":"102","author":"H Rus","year":"2005","unstructured":"Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Guo L et al (2005) The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci USA 102:11094\u201311099","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","volume":"572","author":"N Saligrama","year":"2019","unstructured":"Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, Ji X, Idoyaga J, Mahajan VB et al (2019) Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature 572:481\u2013487","journal-title":"Nature"},{"issue":"8","key":"307_CR73","first-page":"4195","volume":"130","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Nguyen HM, Malovic E, Luo J, Langley M, Palanisamy BN, Singh N, Manne S, Neal M, Gabrielle M et al (2020) Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Clin Investig 130(8):4195\u20134212","journal-title":"J Clin Investig"},{"key":"307_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13046-022-02249-w","volume":"41","author":"F Severin","year":"2022","unstructured":"Severin F, Urbani A, Varanita T, Bachmann M, Azzolini M, Martini V, Pizzi M, Tos APD, Frezzato F, Mattarei A et al (2022) Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model. J Exp Clin Cancer Res 41:64","journal-title":"J Exp Clin Cancer Res"},{"key":"307_CR75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1756285617716002","volume":"10","author":"BA Singer","year":"2017","unstructured":"Singer BA (2017) The role of natalizumab in the treatment of multiple sclerosis: benefits and risks. Ther Adv Neurol Disord 10:327\u2013336","journal-title":"Ther Adv Neurol Disord"},{"key":"307_CR76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0036-1579739","volume":"36","author":"M Sospedra","year":"2016","unstructured":"Sospedra M, Martin R (2016) Immunology of multiple sclerosis. Semin Neurol 36:115\u2013127","journal-title":"Semin Neurol"},{"key":"307_CR77","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/jnr.21645","volume":"86","author":"ME Stokely","year":"2008","unstructured":"Stokely ME, Garg P, Bhat MA, Koulen P (2008) Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles. J Neurosci Res 86:2111\u20132124","journal-title":"J Neurosci Res"},{"key":"307_CR78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1124\/jpet.109.156422","volume":"331","author":"TB Sundberg","year":"2009","unstructured":"Sundberg TB, Swenson L, Wahl DR, Opipari AW Jr, Glick GD (2009) Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes. J Pharmacol Exp Ther 331:437\u2013444","journal-title":"J Pharmacol Exp Ther"},{"key":"307_CR79","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1073\/pnas.0804236105","volume":"105","author":"I Szabo","year":"2008","unstructured":"Szabo I, Bock J, Grassme H, Soddemann M, Wilker B, Lang F, Zoratti M, Gulbins E (2008) Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci USA 105:14861\u201314866","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR80","doi-asserted-by":"crossref","first-page":"12790","DOI":"10.1074\/jbc.M413548200","volume":"280","author":"I Szabo","year":"2005","unstructured":"Szabo I, Bock J, Jekle A, Soddemann M, Adams C, Lang F, Zoratti M, Gulbins E (2005) A novel potassium channel in lymphocyte mitochondria. J Biol Chem 280:12790\u201312798","journal-title":"J Biol Chem"},{"key":"307_CR81","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12464-3","volume":"10","author":"PA Szabo","year":"2019","unstructured":"Szabo PA, Levitin HM, Miron M, Snyder ME, Senda T, Yuan J, Cheng YL, Bush EC, Dogra P, Thapa P et al (2019) Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat Commun 10:4706","journal-title":"Nat Commun"},{"key":"307_CR82","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13040","volume":"32","author":"P Theotokis","year":"2022","unstructured":"Theotokis P, Kesidou E, Mitsiadou D, Petratos S, Damianidou O, Boziki M, Chatzidimitriou A, Grigoriadis N (2022) Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination. Brain Pathol 32:e13040","journal-title":"Brain Pathol"},{"key":"307_CR83","doi-asserted-by":"publisher","unstructured":"Ucciferri CC, Gower A, Alvarez-Sanchez N, Whetstone H, Ramaglia V, Gommerman JL, Brand-Arzamendi K, Schneider R, Dunn SE (2024) Scoring central nervous system inflammation, demyelination, and axon injury in experimental autoimmune encephalomyelitis. J Vis Exp (204):e65738. https:\/\/doi.org\/10.3791\/65738","DOI":"10.3791\/65738"},{"key":"307_CR84","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/ecco-jcc\/jjab078","volume":"15","author":"AL Unterweger","year":"2021","unstructured":"Unterweger AL, Jensen M, Giordanetto F, Jogini V, R\u00fcschher A, Seu\u00df M, Winkelmann P, Koletzko L, Shaw DE, Siebeck M et al (2021) Suppressing Kv1.3 ion channel activity with a novel small molecule inhibitor ameliorates inflammation in a humanised mouse model of ulcerative colitis. J Crohns Colitis 15:1943\u20131958","journal-title":"J Crohns Colitis"},{"key":"307_CR85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/mol.112.078006","volume":"82","author":"Z Varga","year":"2012","unstructured":"Varga Z, Gurrola-Briones G, Papp F, Rodriguez de la Vega RC, Pedraza-Alva G, Tajhya RB, Gaspar R, Cardenas L, Rosenstein Y, Beeton C et al (2012) Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells. Mol Pharmacol 82:372\u2013382","journal-title":"Mol Pharmacol"},{"key":"307_CR86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s42977-021-00071-7","volume":"72","author":"Z Varga","year":"2021","unstructured":"Varga Z, Tajti G, Panyi G (2021) The Kv1.3 K(+) channel in the immune system and its \u201cprecision pharmacology\u201d using peptide toxins. Biol Futur 72:75\u201383","journal-title":"Biol Futur"},{"key":"307_CR87","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-065X.2012.01148.x","volume":"249","author":"DR Wahl","year":"2012","unstructured":"Wahl DR, Byersdorfer CA, Ferrara JL, Opipari AW Jr, Glick GD (2012) Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunol Rev 249:104\u2013115","journal-title":"Immunol Rev"},{"key":"307_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","volume":"37","author":"FR Walker","year":"2014","unstructured":"Walker FR, Beynon SB, Jones KA, Zhao Z, Kongsui R, Cairns M, Nilsson M (2014) Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms. Brain Behav Immun 37:1\u201314","journal-title":"Brain Behav Immun"},{"key":"307_CR89","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang J, Jelcic I, M\u00fchlenbruch L, Haunerdinger V, Toussaint NC, Zhao Y, Cruciani C, Faigle W, Naghavian R, Foege M et al (2020) HLA-DR15 molecules jointly shape an autoreactive T cell repertoire in multiple sclerosis. Cell 183:1264\u20131281.e1220","journal-title":"Cell"},{"key":"307_CR90","volume":"3","author":"Y Wang","year":"2022","unstructured":"Wang Y, Sun B, Shibata B, Guo F (2022) Transmission electron microscopic analysis of myelination in the murine central nervous system. STAR Protoc 3:101304","journal-title":"STAR Protoc"},{"key":"307_CR91","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2011.02.008","volume":"234","author":"JL Williams","year":"2011","unstructured":"Williams JL, Kithcart AP, Smith KM, Shawler T, Cox GM, Whitacre CC (2011) Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. J Neuroimmunol 234:84\u201392","journal-title":"J Neuroimmunol"},{"key":"307_CR92","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.4049\/jimmunol.1601532","volume":"198","author":"Q Wu","year":"2017","unstructured":"Wu Q, Wang Q, Mao G, Dowling CA, Lundy SK, Mao-Draayer Y (2017) Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1\/Th17 and Th2 in multiple sclerosis patients. J Immunol (Baltim, Md: 1950) 198:3069\u20133080","journal-title":"J Immunol (Baltim, Md: 1950)"},{"key":"307_CR93","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI16921","volume":"111","author":"H Wulff","year":"2003","unstructured":"Wulff H, Calabresi PA, Allie R, Yun S, Pennington M, Beeton C, Chandy KG (2003) The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest 111:1703\u20131713","journal-title":"J Clin Invest"},{"issue":"136","key":"307_CR94","first-page":"57648","volume":"5","author":"K Young","year":"2018","unstructured":"Young K, Morrison H (2018) Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp 5(136):57648","journal-title":"J Vis Exp"},{"key":"307_CR95","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/cns.12848","volume":"24","author":"XL Yuan","year":"2018","unstructured":"Yuan XL, Zhao YP, Huang J, Liu JC, Mao WQ, Yin J, Peng BW, Liu WH, Han S, He XH (2018) A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis. CNS Neurosci Ther 24:967\u2013977","journal-title":"CNS Neurosci Ther"},{"key":"307_CR96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/jaut.2001.0520","volume":"17","author":"M Yura","year":"2001","unstructured":"Yura M, Takahashi I, Serada M, Koshio T, Nakagami K, Yuki Y, Kiyono H (2001) Role of MOG-stimulated Th1 type \u201clight up\u201d (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). J Autoimmun 17:17\u201325","journal-title":"J Autoimmun"},{"key":"307_CR97","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12035-010-8098-4","volume":"41","author":"D Zhang","year":"2010","unstructured":"Zhang D, Hu X, Qian L, O\u2019Callaghan JP, Hong JS (2010) Astrogliosis in CNS pathologies: is there a role for microglia?. Mol Neurobiol 41:232\u2013241","journal-title":"Mol Neurobiol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00307-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00307-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00307-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:59:18Z","timestamp":1786971558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00307-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":97,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,10]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00307-2","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"5"}}